Coronary dilatation reserve in experimental hypertension and chronic heart failure: Effects of blockade of the renin-angiotensin system

被引:4
作者
Richer, C
Domergue, V
Gervais, M
Fornes, P
Trabold, F
Giudicelli, JF
机构
[1] Fac Med Paris Sud, Dept Pharmacol, F-94276 Le Kremlin Bicetre, France
[2] Fac Med Paris Sud, INSERM 00 01, F-94276 Le Kremlin Bicetre, France
关键词
cardiac remodelling; congestive heart failure; coronary vasodilatation reserve; hypertension; kallikrein-kinin system; renin-angiotensin system;
D O I
10.1046/j.1440-1681.2001.03573.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. The aim of the present study was to investigate left and right ventricular (LV and RV, respectively) coronary vasodilatation reserve (CVR; fluorescent microsphere technique) in rats with hypertension (spontaneously hypertensive rats (SHR)) or congestive heart failure (CHF) and the effects of early and chronic renin-angiotensin system (RAS) blockade thereupon. 2. In adult SHR, both LV and RV CVR were impaired, especially in the non-hypertrophied RV, the main factor involved being coronary vascular remodelling. Blockade of the RAS normalized both LV and RV CVR, mainly through the prevention of hypertension and suppression of the resulting pericoronary fibrosis. 3. In postischaemic CHF rats, there was an early and severe degradation of LV and RV CVR that developed before any significant vascular remodelling and appeared to be linked to the deterioration of cardiac hypertrophy and haemodynamics. This degradation in CVR further worsened over the longer term due to late-developing pericoronary fibrosis and endothelial dysfunction. Blockade of the RAS had no early effects on LV and RV CVR, but improved RV CVR over the long term, mainly by limiting RV hypertrophy and by preventing the development of pericoronary fibrosis and coronary endothelial dysfunction. 4. In kallikrein-kinin system-deficient mice, CVR was not different from that of wild-type mice, suggesting that this system is not implicated in normal CVR regulation.
引用
收藏
页码:997 / 1001
页数:5
相关论文
共 16 条
[1]   Effect of angiotensin-converting enzyme inhibition on myocardial vascularization in the adolescent and adult spontaneously hypertensive rat [J].
Black, MJ ;
Bertram, JF ;
Johnston, CI .
JOURNAL OF HYPERTENSION, 2001, 19 (04) :785-794
[2]   Systemic and regional hemodynamics assessment in rats with fluorescent microspheres [J].
Gervais, M ;
Démolis, P ;
Domergue, V ;
Lesage, M ;
Richer, C ;
Giudicelli, JF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1999, 33 (03) :425-432
[3]   Effects of angiotensin II AT1-receptor blockade on coronary dynamics, function, and structure in postischemic heart failure in rats [J].
Gervais, M ;
Fornes, P ;
Richer, C ;
Nisato, D ;
Giudicelli, JF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (03) :329-337
[4]   MAXIMAL CORONARY FLOW AND THE CONCEPT OF CORONARY VASCULAR RESERVE [J].
HOFFMAN, JIE .
CIRCULATION, 1984, 70 (02) :153-159
[5]  
Klepzig M, 1987, J Cardiovasc Pharmacol, V10 Suppl 6, pS97, DOI 10.1097/00005344-198706106-00013
[6]   DIFFERENT MECHANISMS OF ENDOTHELIAL DYSFUNCTION WITH AGING AND HYPERTENSION IN RAT AORTA [J].
KUNG, CF ;
LUSCHER, TF .
HYPERTENSION, 1995, 25 (02) :194-200
[7]   Cardiovascular abnormalities with normal blood pressure in tissue kallikrein-deficient mice [J].
Meneton, P ;
Bloch-Faure, M ;
Hagege, AA ;
Ruetten, H ;
Huang, W ;
Bergaya, S ;
Ceiler, D ;
Gehring, D ;
Martins, I ;
Salmon, G ;
Boulanger, CM ;
Nussberger, J ;
Crozatier, B ;
Gasc, JM ;
Heudes, D ;
Bruneval, P ;
Doetschman, T ;
Ménard, J ;
Alhenc-Gelas, F .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (05) :2634-2639
[8]   LEFT-VENTRICULAR REMODELING FOLLOWING EXPERIMENTAL MYOCARDIAL-INFARCTION [J].
MICHEL, JB ;
NICOLLETTI, A ;
ARNAL, JF .
EUROPEAN HEART JOURNAL, 1995, 16 :49-57
[9]   ENDOTHELIAL AND SMOOTH-MUSCLE PROPERTIES OF CORONARY AND MESENTERIC RESISTANCE ARTERIES IN SPONTANEOUSLY HYPERTENSIVE RATS COMPARED TO WKY RATS [J].
POURAGEAUD, F ;
FRESLON, JL .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1995, 9 (01) :37-45
[10]   Fluospheres for cardiovascular phenotyping genetically modified mice [J].
Richer, C ;
Domergue, V ;
Gervais, M ;
Bruneval, P ;
Giudicelli, JF .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2000, 36 (03) :396-404